vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and SunOpta Inc. (STKL). Click either name above to swap in a different company.
SunOpta Inc. is the larger business by last-quarter revenue ($205.4M vs $123.8M, roughly 1.7× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs 0.4%, a 2.9% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs 4.7%). SunOpta Inc. produced more free cash flow last quarter ($12.1M vs $7.6M). Over the past eight quarters, SunOpta Inc.'s revenue compounded faster (7.4% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.
NATR vs STKL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $205.4M |
| Net Profit | $4.1M | $816.0K |
| Gross Margin | 72.5% | 12.4% |
| Operating Margin | 4.3% | 3.3% |
| Net Margin | 3.3% | 0.4% |
| Revenue YoY | 4.7% | 16.6% |
| Net Profit YoY | 1379.4% | 113.1% |
| EPS (diluted) | $0.23 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | — | ||
| Q3 25 | $128.3M | $205.4M | ||
| Q2 25 | $114.8M | $191.5M | ||
| Q1 25 | $113.2M | $201.6M | ||
| Q4 24 | $118.2M | $193.9M | ||
| Q3 24 | $114.6M | $175.9M | ||
| Q2 24 | $110.6M | $169.5M | ||
| Q1 24 | $111.0M | $184.4M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $816.0K | ||
| Q2 25 | $5.3M | $4.4M | ||
| Q1 25 | $4.7M | $4.8M | ||
| Q4 24 | $-321.0K | $-8.7M | ||
| Q3 24 | $4.3M | $-6.2M | ||
| Q2 24 | $1.3M | $-5.3M | ||
| Q1 24 | $2.3M | $2.9M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | 12.4% | ||
| Q2 25 | 71.7% | 14.8% | ||
| Q1 25 | 72.1% | 15.0% | ||
| Q4 24 | 72.0% | 10.9% | ||
| Q3 24 | 71.3% | 13.0% | ||
| Q2 24 | 71.4% | 12.5% | ||
| Q1 24 | 71.2% | 16.8% |
| Q4 25 | 4.3% | — | ||
| Q3 25 | 7.0% | 3.3% | ||
| Q2 25 | 3.7% | 5.5% | ||
| Q1 25 | 5.4% | 5.2% | ||
| Q4 24 | 3.8% | 1.4% | ||
| Q3 24 | 4.6% | 0.5% | ||
| Q2 24 | 5.1% | 1.2% | ||
| Q1 24 | 4.2% | 5.5% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | 0.4% | ||
| Q2 25 | 4.6% | 2.3% | ||
| Q1 25 | 4.2% | 2.4% | ||
| Q4 24 | -0.3% | -4.5% | ||
| Q3 24 | 3.8% | -3.5% | ||
| Q2 24 | 1.2% | -3.1% | ||
| Q1 24 | 2.1% | 1.6% |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.30 | $0.01 | ||
| Q2 25 | $0.28 | $0.03 | ||
| Q1 25 | $0.25 | $0.04 | ||
| Q4 24 | $-0.02 | $-0.08 | ||
| Q3 24 | $0.23 | $-0.05 | ||
| Q2 24 | $0.07 | $-0.04 | ||
| Q1 24 | $0.12 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $2.2M |
| Total DebtLower is stronger | — | $250.8M |
| Stockholders' EquityBook value | $161.6M | $162.8M |
| Total Assets | $261.1M | $694.1M |
| Debt / EquityLower = less leverage | — | 1.54× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | — | ||
| Q3 25 | $95.6M | $2.2M | ||
| Q2 25 | $81.3M | $2.2M | ||
| Q1 25 | $86.5M | $2.3M | ||
| Q4 24 | $84.7M | $1.6M | ||
| Q3 24 | $78.7M | $2.9M | ||
| Q2 24 | $68.7M | $3.2M | ||
| Q1 24 | $77.8M | $1.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $250.8M | ||
| Q2 25 | — | $263.3M | ||
| Q1 25 | — | $260.6M | ||
| Q4 24 | — | $265.2M | ||
| Q3 24 | — | $289.9M | ||
| Q2 24 | — | $303.1M | ||
| Q1 24 | $2.1M | $258.8M |
| Q4 25 | $161.6M | — | ||
| Q3 25 | $166.7M | $162.8M | ||
| Q2 25 | $163.7M | $159.8M | ||
| Q1 25 | $167.1M | $154.8M | ||
| Q4 24 | $161.0M | $148.6M | ||
| Q3 24 | $162.6M | $155.0M | ||
| Q2 24 | $156.4M | $158.8M | ||
| Q1 24 | $159.7M | $163.6M |
| Q4 25 | $261.1M | — | ||
| Q3 25 | $264.8M | $694.1M | ||
| Q2 25 | $254.9M | $704.9M | ||
| Q1 25 | $252.7M | $690.7M | ||
| Q4 24 | $240.9M | $668.5M | ||
| Q3 24 | $245.3M | $699.3M | ||
| Q2 24 | $235.8M | $704.7M | ||
| Q1 24 | $247.3M | $671.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.54× | ||
| Q2 25 | — | 1.65× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | 0.01× | 1.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $16.3M |
| Free Cash FlowOCF − Capex | $7.6M | $12.1M |
| FCF MarginFCF / Revenue | 6.1% | 5.9% |
| Capex IntensityCapex / Revenue | 1.9% | 2.1% |
| Cash ConversionOCF / Net Profit | 2.41× | 20.03× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $36.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | — | ||
| Q3 25 | $18.5M | $16.3M | ||
| Q2 25 | $4.3M | $-4.5M | ||
| Q1 25 | $2.6M | $22.3M | ||
| Q4 24 | $12.2M | $33.1M | ||
| Q3 24 | $9.6M | $17.2M | ||
| Q2 24 | $1.3M | $-5.6M | ||
| Q1 24 | $2.2M | $5.3M |
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | $12.1M | ||
| Q2 25 | $3.0M | $-9.2M | ||
| Q1 25 | $1.5M | $9.5M | ||
| Q4 24 | $10.0M | $24.0M | ||
| Q3 24 | $7.9M | $11.7M | ||
| Q2 24 | $-2.0M | $-15.3M | ||
| Q1 24 | $-1.5M | $-2.3M |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | 5.9% | ||
| Q2 25 | 2.6% | -4.8% | ||
| Q1 25 | 1.3% | 4.7% | ||
| Q4 24 | 8.5% | 12.4% | ||
| Q3 24 | 6.9% | 6.6% | ||
| Q2 24 | -1.9% | -9.0% | ||
| Q1 24 | -1.4% | -1.2% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | 2.1% | ||
| Q2 25 | 1.2% | 2.5% | ||
| Q1 25 | 1.0% | 6.3% | ||
| Q4 24 | 1.9% | 4.7% | ||
| Q3 24 | 1.5% | 3.2% | ||
| Q2 24 | 3.0% | 5.7% | ||
| Q1 24 | 3.3% | 4.1% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 20.03× | ||
| Q2 25 | 0.81× | -1.03× | ||
| Q1 25 | 0.55× | 4.63× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | 1.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
STKL
| Beverages And Broths | $161.4M | 79% |
| Fruit Snacks | $40.9M | 20% |
| Ingredients | $3.1M | 2% |
